Tolterodine Tartrate Articles
Pfizer links with SFJ Pharma for dacomitinib trial; settles with Mylan
10 September 2012
FDA eyes orlistat for potential liver problems, Chantix under scrutiny for skin reaction
5 June 2009
US FDA approves Pfizer's Toviaz
10 November 2008
Wal-Mart price war aimed at PBMs
19 May 2008
Pfizer
23 July 2007
Pfizer's 1st-qtr profits tumble 17.5%
30 April 2007
Pfizer pulls out of accord with Altana on Daxas
11 July 2005
Japan stock market week to March 28
4 April 2005
Indevus files for OAB drug trospium in USA
5 May 2003
Further progress for Pfizer/Pharmacia deal
31 March 2003
Pfizer merger oked by EC but not without cost
10 March 2003
Watson's incontinence patch cleared by US FDA
3 March 2003
Pharmacia's earnings match forecasts in 2002
24 February 2003
Update: Pharmacia's earnings match forecasts in 2002
24 February 2003
Pharmacia EPS up by 8% in 2nd-quarter
29 July 2002
Pharmacia intent on "doubling Japanese sales"
24 June 2002
Pharmacia sales take a dip in first quarter
29 April 2002
Watson says oxybutynin patch effective
18 February 2002
Pharmacia 4th-qtr profits take a dip but Celebrex still selling well
11 February 2002
Pharmacia's product pipeline; what's in store after Celebrex?
29 November 2001
Pharmacia EPS rises 24% in third quarter
24 October 2001
Interneuron begins Ph III trospium trial
7 September 2001
Urinary incontinence market forecasts
10 August 2001
Pharmacia earnings up 20%, sales rise 5%
25 July 2001
Ditropan XL vs Detrol study in incontinence
11 April 2001
Pharmacia fourth-quarter earnings jump 32%, driven by Celebrex sales
13 February 2001
Pharmacia plans for Japanese market
21 July 2000
Pharmacia's EPS up 27% in 1st quarter
26 April 2000
Stock Commentary Europe
16 March 2000
Once-daily Detrol filed
8 March 2000
J&J ends Alza JV for E-TRANS - update
23 February 2000
J&J ends Alza JV for E-TRANS
18 February 2000
Pharmacia & Upjohn and Monsanto both post strong results for 1999
11 February 2000
P&U files NDA for new glaucoma combination
11 January 2000
P&U continues turnaround, looking for 1999 double-digit growth
29 October 1999
Pharmacia & Upjohn net income up 47%
2 August 1999
UK MCA clears P&U bladder health ads
29 July 1999
Pharmacia & Upjohn earnings up 17%
5 May 1999
P&U posts strong growth for 1998
12 February 1999
Alza's Ditropan XL cleared by FDA- updated story
7 January 1999
Pharmacia & Upjohn Posts Strong Growth For 3rd Qtr
3 November 1998
Pharmacia & Upjohn Turnaround Continuing
31 July 1998
Detrol Doing Well
30 June 1998
P&U Sales Up, Says Turnaround Is On Track
30 April 1998
P&U's Detrusitol Selling Well
9 April 1998
FDA Approval News In Brief
2 April 1998
P&U's Detrusitol
12 March 1998
Pramipexole Approved In The European Union
5 March 1998
Showing 1-62 of 62 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
